000			02328 a2200649 4500
005			20250517035724.0
264		0	_c20160517
008			201605s 0 0 eng d
022			_a1879-0712
024	7		_a10.1016/j.ejphar.2015.06.018 _2doi
040			_aNLM _beng _cNLM
100	1		_aPugsley, Michael K
245	0	0	_aAn examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist. _h[electronic resource]
260			_bEuropean journal of pharmacology _cAug 2015
300			_a330-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAction Potentials
650	0	4	_aAnimals
650	0	4	_aAnti-Arrhythmia Agents _xmetabolism
650	0	4	_aArrhythmias, Cardiac _xetiology
650	0	4	_aBinding, Competitive
650	0	4	_aCardiac Pacing, Artificial
650	0	4	_aCerebellum _xdrug effects
650	0	4	_aCoronary Occlusion _xcomplications
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aElectrocardiography
650	0	4	_aGuinea Pigs
650	0	4	_aHeart Conduction System _xdrug effects
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHeart Ventricles _xdrug effects
650	0	4	_aIsolated Heart Preparation
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aPain _xmetabolism
650	0	4	_aPain Threshold _xdrug effects
650	0	4	_aPotassium Channel Blockers _xpharmacology
650	0	4	_aPotassium Channels _xdrug effects
650	0	4	_aProtein Binding
650	0	4	_aPyrroles _xmetabolism
650	0	4	_aRadioligand Assay
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Opioid, kappa _xdrug effects
650	0	4	_aSodium Channel Blockers _xpharmacology
650	0	4	_aSodium Channels _xdrug effects
650	0	4	_aThiophenes _xmetabolism
650	0	4	_aVentricular Function, Left _xdrug effects
650	0	4	_aVentricular Pressure _xdrug effects
700	1		_aSaint, David A
700	1		_aHayes, Eric S
700	1		_aAbraham, Shlomo
700	1		_aWalker, Michael J A
773	0		_tEuropean journal of pharmacology _gvol. 761 _gp. 330-40
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2015.06.018 _zAvailable from publisher's website
999			_c24993922 _d24993922